SWANGCHAICHUAN (02321) announced its annual performance, with a net profit of 33.238 million ringgit, an increase of 18.44% year-on-year.
Shuangcai Group (02321) announced its annual results as at December 31, 2025. The group achieved revenue of 933 million Malaysian Ringgit, an increase of 2.2% compared to the previous year; net profit for the year was 332.38 million Malaysian Ringgit, an increase of 18.44% compared to the previous year; earnings per share were 3.32 Malaysian Ringgit cents.
SWANGCHAICHUAN (02321) announced its annual performance for the year ending December 31, 2025. The group achieved a revenue of 933 million Malaysian Ringgit, an increase of 2.2% compared to the previous year. The net profit for the year was 332.38 million Malaysian Ringgit, an increase of 18.44% compared to the previous year. Earnings per share were 3.32 Malaysian Ringgit cents.
The announcement stated that the increase in revenue from third-party brands was mainly attributed to personal care and baby care products, cleaning and kitchen supplies, beverages, frozen foods and sauces, and oils and seasonings, which increased by approximately 47.1 million Malaysian Ringgit, offsetting the decrease in sales of packaged foods and merchandise by 26.5 million Malaysian Ringgit.
Related Articles

ZGC TEC LEASING (01601) and Beijing Yi Longhengye Petroleum Engineering Technology sign a financing lease agreement.
.png)
CRYOFOCUS-B (06922) releases its annual performance report, showing a net loss of 44.456 million yuan for the year, a 60% decrease compared to the previous year.

Sinotruk Jinan Truck (03808): Zhao Hang appointed as a member of the company's Remuneration Committee.
ZGC TEC LEASING (01601) and Beijing Yi Longhengye Petroleum Engineering Technology sign a financing lease agreement.

CRYOFOCUS-B (06922) releases its annual performance report, showing a net loss of 44.456 million yuan for the year, a 60% decrease compared to the previous year.
.png)
Sinotruk Jinan Truck (03808): Zhao Hang appointed as a member of the company's Remuneration Committee.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


